Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Curis Inc (CRIS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,677
  • Shares Outstanding, K 33,151
  • Annual Sales, $ 10,430 K
  • Annual Income, $ -32,580 K
  • 60-Month Beta 2.14
  • Price/Sales 5.79
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.33 +33.08%
on 03/21/19
2.65 -33.21%
on 03/25/19
+0.36 (+25.53%)
since 03/18/19
3-Month
0.99 +78.79%
on 02/14/19
2.65 -33.21%
on 03/25/19
+0.61 (+52.59%)
since 01/18/19
52-Week
0.60 +195.00%
on 12/11/18
3.33 -46.85%
on 05/31/18
-1.23 (-41.00%)
since 04/18/18

Most Recent Stories

More News
Healthcare Companies Search for New Ways to Oppose the Spread of Cancer

Cancer is among one of the leading causes of death in the world since many countries are burdened by the lack of access to adequate healthcare, which results in the high number of deaths. In 2018, the...

CRIS : 1.77 (-2.75%)
CVM : 5.95 (+2.94%)
GERN : 1.77 (+1.72%)
SNETD : 0.3900 (+14.71%)
SNET : 0.0240 (unch)
NLNK : 1.59 (+1.27%)
Research Report Identifies Denison Mine, Obsidian Energy, Cherry Hill Mortgage Investment, Curis, DASAN Zhone Solutions, and CVD Equipment with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Denison Mine Corp (NYSE:DNN), Obsidian...

CVV : 3.74 (+1.91%)
OBE : 0.32 (unch)
DNN : 0.53 (-1.15%)
CRIS : 1.77 (-2.75%)
DZSI : 10.45 (+1.16%)
CHMI : 17.31 (-0.35%)
Curis Regains Compliance with Nasdaq Continued Listing Requirements

Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, announced today that it received written confirmation from the Listing...

CRIS : 1.77 (-2.75%)
Curis Announces Advancement to the 200mg BID Cohort in the CA-4948 Study

Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, announced today that it has begun dosing patients in the 5th cohort...

CRIS : 1.77 (-2.75%)
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on April 2, 2019, the independent Compensation...

CRIS : 1.77 (-2.75%)
Curis: 4Q Earnings Snapshot

LEXINGTON, Mass. (AP) _ Curis Inc. (CRIS) on Tuesday reported a loss of $5.9 million in its fourth quarter.

CRIS : 1.77 (-2.75%)
Curis Reports Fourth Quarter and Year-End 2018 Financial Results

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today reported its financial results for the fourth quarter and year...

CRIS : 1.77 (-2.75%)
Thinking about buying stock in Aldeyra Therapeutics, Bed Bath & Beyond Inc., Curis Inc., Cronos Group Inc., or Hunter Maritime Acquisition Corp.?

InvestorsObserver issues critical PriceWatch Alerts for ALDX, BBBY, CRIS, CRON, and HUNT.

CRIS : 1.77 (-2.75%)
BBBY : 17.41 (+0.75%)
HUNTU : 88.00 (+310.45%)
How Leukemia Clinical Trials are Helping Practitioners Personalize Patient Care

At present, medical practitioners have few options when they are presented with a patient with leukemia. The Leukemia & Lymphoma Society's website points out that : "It's important that your doctor is...

CRIS : 1.77 (-2.75%)
GILD : 62.95 (-0.47%)
TEVA : 14.36 (+0.98%)
NK : 1.16 (-6.45%)
MBRX : 1.11 (+14.08%)
Curis Sells Portion of Erivedge Royalties to Oberland Capital for up to $135.7 million

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into an agreement with funds managed...

CRIS : 1.77 (-2.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade CRIS with:

Business Summary

Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate...

See More

Key Turning Points

2nd Resistance Point 1.88
1st Resistance Point 1.82
Last Price 1.77
1st Support Level 1.74
2nd Support Level 1.72

See More

52-Week High 3.33
Fibonacci 61.8% 2.29
Fibonacci 50% 1.96
Last Price 1.77
Fibonacci 38.2% 1.64
52-Week Low 0.60

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar